Martelletti, Paolo
자료유형 | 단행본 |
---|---|
개인저자 | Martelletti, Paolo.,editor. Edvinsson, Lars.,editor. |
단체저자명 | SpringerLink (Online service). |
서명/저자사항 | Novel Synthetic Drugs in Migraine [electronic resource] / edited by Paolo Martelletti, Lars Edvinsson. |
판사항 | 1st ed. 2022. |
형태사항 | IX, 109 p. 5 illus:online resource. |
총서사항 | Headache=2197-6538 |
총서부출표목 | Headache, |
기본자료 저록 | Springer Nature eBook |
기타형태 저록 | Printed edition:9783030953331Printed edition:9783030953355Printed edition:9783030953362 |
ISBN | 9783030953348 |
기타표준부호 | 10.1007/978-3-030-95334-8 |
요약 | Published in the series Headache, endorsed by the European Headache Federation, this is the first book on the novel synthetic treatment of migraine with ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant). These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature published to interest a wide multidisciplinary readership (general physicians, general neurologists, clinical psychologists, neurologists in training, and medical students) facing every day this burdensome disorder in their clinical practice. The book aims therefore at offering an overview of these new drugs for both acute and prophylactic treatments of migraine, covering studies on clinical evidence, tolerability, and the different stages of clinical development. |
일반주제명 | Internal medicine. Neurology . Emergency medicine. Pain medicine. Pharmacology. Internal Medicine. Neurology. Emergency Medicine. Pain Medicine. Pharmacology. |
바로가기 | URL |